mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.7 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.7 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |